NCF TeamMar 26, 20256 min readPositive Results of the CABINET Trial Show Cabozantinib as a New, Effective Treatment in Advanced Neuroendocrine Tumors
NCF TeamDec 6, 20242 min readLACNETS at the 2024 North American Neuroendocrine Tumor Society (NANETS) Annual Multidisciplinary NET Medical Professional Symposium
